Actym Therapeutics, Inc. Funding: $60M Raised, Series A
Actym Therapeutics, Inc. is based in Berkeley, California. It has raised $60M in total funding. Latest round: Series A.
Actym Therapeutics, Inc. funding overview
Actym Therapeutics, Inc. is based in Berkeley, California. Actym Therapeutics, Inc. has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2023. The round record for Actym Therapeutics, Inc. runs through 2023; nothing later has been disclosed. Investors on record include Illumina Ventures, Boehringer Ingelheim Venture Fund, GKCC LLC, JLo Ventures, Panacea Venture. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Actym Therapeutics, Inc. funding
How much has Actym Therapeutics, Inc. raised?
Actym Therapeutics, Inc. has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Actym Therapeutics, Inc.?
Illumina Ventures, Boehringer Ingelheim Venture Fund, GKCC LLC, JLo Ventures, Panacea Venture are named among the investors backing Actym Therapeutics, Inc..
What was the latest Actym Therapeutics, Inc. funding round?
The most recent disclosed round is a Series A, announced in October 2023.
Where is Actym Therapeutics, Inc. based?
Actym Therapeutics, Inc. is based in Berkeley, California.
When did Actym Therapeutics, Inc. last raise?
The last disclosed Actym Therapeutics, Inc. round closed in October 2023 at Series A.
We update the Actym Therapeutics, Inc. record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Berkeley and their backers are listed below.
Companies related to Actym Therapeutics, Inc. (32)
